A/Prof Oliver Klein has undertaken his training in Medical Oncology and Clinical Haematology in Germany joining the Ludwig Institute for Cancer Research at the Austin Hospital in 2005. He has worked for several years as a postdoctoral and clinical research fellow, being actively involved in melanoma and cancer immunotherapy research.

With extensive experience in the management of patients with melanoma and a particular interest in immuno-oncology, he has lead an investigator-initiated clinical trial that demonstrated unprecedented clinical efficacy of immunotherapy, using checkpoint inhibitors in patients with advanced rare cancers. His research is focused on exploring the most up-to-date and novel way to treat cancer, by harnessing the body’s immune system’s ability to fight cancer. He currently is involved in numerous clinical trials and continues to publish in scientific journals and present at national and international conferences.